Vident Investment Advisory’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-22,951
| Closed | -$858K | – | 984 |
|
|
2018
Q1 | $858K | Buy |
22,951
+6,224
| +37% | +$233K | 0.03% | 420 |
|
|
2017
Q4 | $1.22M | Buy |
+16,727
| New | +$1.22M | 0.06% | 348 |
|
|
2017
Q2 | – | Sell |
-8,961
| Closed | -$1.94M | – | 455 |
|
|
2017
Q1 | $1.94M | Buy |
8,961
+1,493
| +20% | +$324K | 0.19% | 260 |
|
|
2016
Q4 | $691K | Buy |
7,468
+415
| +6% | +$38.4K | 0.08% | 317 |
|
|
2016
Q3 | $953K | Buy |
7,053
+48
| +0.7% | +$6.49K | 0.13% | 299 |
|
|
2016
Q2 | $710K | Buy |
7,005
+2,617
| +60% | +$265K | 0.1% | 314 |
|
|
2016
Q1 | $718 | Buy |
4,388
+2,048
| +88% | +$335 | 0.04% | 361 |
|
|
2015
Q4 | $766K | Buy |
2,340
+1,660
| +244% | +$543K | 0.1% | 340 |
|
|
2015
Q3 | $219K | Buy |
+680
| New | +$219K | 0.03% | 720 |
|